Penrod

MARCH 7, 2024

Digital patient forms offer a superior solution for the healthcare sector, swiftly supplanting traditional paperwork. Paper Forms are Inefficient Manually filling out, sorting, and storing paper forms is a time-consuming task that hampers the efficiency and productivity of healthcare professionals. Here’s why.

Healthcare 52

Healthcare Healthcare Patients Leads 52

Eversana Intouch

MARCH 19, 2024

And this month, we’re bringing to light the challenges in women’s healthcare that we can help solve and make history together. When it comes to healthcare, however, this model often fails to consider the good of all. That’s why in 2024, we find ourselves still failing women in healthcare.

Healthcare 59

Healthcare Healthcare Marketing Prescription 59

PM360

JUNE 23, 2023

Press Release Contact: Kayla Walsh Awards Coordinator, PM360 646-300-8114 kayla.walsh@pm360online.com PM360 Now Accepting Entries for 2024 Pharma Choice Awards Call for the Best Healthcare Creative from the Past Year NEW YORK, NY, June 22, 2023 : The 2024 PM360 Pharma Choice Awards are officially open for entries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

PM360

FEBRUARY 8, 2024

Elevate Healthcare and LivaNova USA, Inc. VNS Therapy is a Life-changer VNS (vagus nerve stimulation) Therapy is designed for people living with seizures despite trying multiple medications. The campaign helped showcase the ability of VNS patients to experience improved quality of life by illustrating everyday activities.

Pharma 52

Pharma Sales Management Healthcare 52

PM360

FEBRUARY 12, 2024

Clinical Research Pain Points The clinical trial process is foundational for transforming robust research into pivotal strides in healthcare innovation. This trial model, in turn, leads to more sucess with better data collection and more diverse treatment options.

Food and Drug Administration 105

Food and Drug Administration Patients Networking Medical 105

Nixon Gwilt Law

APRIL 22, 2024

That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. HIPAA is the pantheon of healthcare data privacy regulation in the U.S. HIPAA What is it?

Healthcare 52

Healthcare Healthcare Training Food and Drug Administration 52

European Pharmaceutical Review

APRIL 17, 2024

Roche multiple sclerosis subcutaneous injection: late-breaking data “Updated results from OCARINA II further underline the potential benefits of subcutaneous OCREVUS for patients with both relapsing and progressive forms of MS,” shared Scott Newsome , DO, lead author, Johns Hopkins University School of Medicine.

Food and Drug Administration 70

Food and Drug Administration Safety Medicine Food 70

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Contact us to learn more about the Mainland China healthcare market and disease-specific trends.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

DECEMBER 12, 2023

Established a decade ago, the PM360 ELITE honors 100 of the top individuals and marketing teams across the healthcare and life sciences industries each year. The initial deadline for submissions is February 23, 2024. PM360 will then continue to accept entries until March 15, 2024, but anything after Feb.

Education 52

Education Healthcare Healthcare Marketing 52

PM360

DECEMBER 17, 2023

Publicis Groupe announced the appointment of Stephen Farquhar as Chief Executive Officer of Publicis Health, effective February 1, 2024. In his new role, Farquhar will be responsible for leading Publicis Health businesses in the U.S., In his new role, Farquhar will be responsible for leading Publicis Health businesses in the U.S.,

Media 52

Media Healthcare Healthcare Leads 52

Eversana Intouch

MARCH 15, 2024

In a recent article published by Med Ad News and PharmaLive.com , Hattie Stearns, Senior Director of Experience DesignOps, provides five key takeaways she observed as a brand and design lead at SXSW 2024.

Marketing 79

Marketing Leads Healthcare Healthcare 79

PM360

JANUARY 16, 2024

Chris Savage, Managing Director, PROPENSITY4 [Fort Washington, PA – 2024] – Inizio Engage is pleased to announce the appointment of Chris Savage as the Managing Director of PROPENSITY4, effective January 1, 2024.

Management 52

Management Consulting Healthcare Healthcare 52

Clarivate

MAY 1, 2024

We took a look at these drugs’ impact on the medtech sector for our forthcoming report, Medtech Trends to Watch in 2024 , and found a more nuanced picture. You can register for the webinar here. The post What GLP-1 drugs mean for medtech appeared first on Clarivate.

Side effects 59

Side effects Physicians Medical Patients 59

PM360

DECEMBER 20, 2023

listed on the stock exchanges, is up 13%, according to Leerink Partners’ “Navigating the Complex Terrain: Healthcare and Biotech Markets in Q3 2023” report. Learn more about why each company went with its respective strategy and the current outlook for each company in 2024 and beyond. The deal is expected to close in 2024.

Management 109

Management Marketing Healthcare Healthcare 109

PM360

FEBRUARY 8, 2024

leading technology provider for modern clinical trials, is using a new intelligent automation technology to provide faster build of standard trial timelines. In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient- centric trials from Medable.” Medable, Inc., Medable, Inc.,

Media 52

Media Electronics Patients Healthcare 52

PM360

MARCH 22, 2024

and is one of the leading causes of kidney failure. As of January 10, 2024, four PKD-free babies have been born as part of our 100 PKD-Free Babies initiative and more than 50 families are now part of our program,” said Richard Kellner founder of the PKD Outreach Foundation. National Healthcare Benchmark Database.

Food and Drug Administration 52

Food and Drug Administration FDA Healthcare Healthcare 52

World of DTC Marketing

DECEMBER 4, 2020

SUMMARY: McKinsey estimates that global digital-health revenues—from telemedicine, online pharmacies, wearable devices, and so on—will rise from $350bn last year to $600bn in 2024. Digital healthcare will increase, but the idea that it could increase so quickly is myopic. I’m not so sure. EHR’s have been a failure.

Medicine 201

Medicine Doctors Medical Media 201

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 97

Medicine Healthcare Healthcare Pharma 97

Pharmaceutical Technology

FEBRUARY 21, 2023

Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine via an Emergency Use Authorisation (EUA) on December 21, 2020.

Sales 98

Sales Government Leads Medicine 98

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. Continuing to increase frequency in multi- channel messaging with less effectiveness can lead to a data deluge.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 is to acquire the 2015-established Amryt Pharma Plc. on 6 th January.

Pharma 93

Pharma Biopharma Management Medicine 93

Legacy MEDSearch

AUGUST 17, 2023

This enhanced functionality will be made available commercially in 2024. The receipt of our 10 th 510(k) clearance is another milestone demonstrating Welldoc’s commitment to leading innovation in digital health. Welldoc continues to be recognized for our leadership, innovation and partnership across the healthcare industry.

FDA 52

FDA Food and Drug Administration Recruitment Management 52

Healthcare Success

APRIL 8, 2024

In the highly saturated healthcare market—where strategic decisions directly influence business growth—the 7 Ps act as a fundamental compass, often separating amateurs from professionals. However, if you’re crossing an ocean, the slightest miscalculation could lead you astray, steering you toward an entirely different continent.

Marketing 112

Marketing Competition Patients Healthcare 112

pharmaphorum

AUGUST 11, 2022

Avalere President Elizabeth Carpenter explained, “Malnutrition is a significant concern in the Medicare population, leading to increased readmissions, higher costs, and longer length of stay. Avalere Health joined Fishawack Health in June 2022.

Electronics 52

Electronics Consulting Healthcare Healthcare 52

Pharmaceutical Technology

MAY 16, 2023

UniQure is selling a part of its royalty rights to the haemophilia B gene therapy Hemgenix (etranacogene dezaparvovec) to HealthCare Royalty and Sagard Healthcare for a gross purchase price of up to $400 million dollars. HealthCare Royalty is a royalty acquisition company. HealthCare Royalty is a royalty acquisition company.

Food and Drug Administration 52

Food and Drug Administration Healthcare Healthcare Sales 52

Legacy MEDSearch

MAY 26, 2023

From 2024, Biosency will make its BVS 3 technology available to healthcare professionals for integration into the BORA Care® digital medical device, with the aim of obtaining reimbursement as part of an advance payment scheme. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide.

Medical 52

Medical Recruitment Management Patients 52

Impetus Digital

JULY 15, 2022

Here in Canada , the inflation rate is not forecasted to come back down to “normal” levels until 2024. If anything, it is more crucial than ever to gather insights from healthcare providers, payers, and patients on current market conditions. Your custom ers’ needs have not gone away just because prices are up.

Healthcare Provider 95

Healthcare Provider Food Pharma Healthcare 95

PM360

DECEMBER 14, 2023

For 12 years, PM360 , a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has recognized the most ground-breaking innovations of this industry as well as from other organizations that serve the life sciences and healthcare in its annual Innovations Issue.

Insurance 64

Insurance Marketing Healthcare Healthcare 64

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst. Pillo, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? We asked our team to share their insights on healthcare innovation, new regulations, and trends we expect to impact your business this year. We know a few!

Healthcare 52

Healthcare Healthcare Management Insurance 52

pharmaphorum

OCTOBER 3, 2022

Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time. It can lead to progressive paralysis and death. Indeed, the concern is the potentially larger problem this could create for the healthcare system as a whole.

Insurance 52

Insurance Prescription FDA Patients 52

pharmaphorum

SEPTEMBER 29, 2022

The sensors are coupled with a mobile app to gather data and a brain dysfunction monitoring app, plus a proprietary algorithm which collates the data onto a clinician dashboard, and the platform allows direct, two-way communication between patient and healthcare professional.

Patients 52

Patients Management Consulting FDA 52

PM360

NOVEMBER 14, 2023

However, in August news outlets reported that even with industry and government initiatives to lower the cost of insulin, the implementation had been slow due to healthcare system “mechanics,” and a significant number of consumers had not yet benefited from the $35 insulin options. for only $35. General Medicines at Sanofi. “We

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

PM360

MARCH 22, 2024

Due to the low prevalence of RD and the international scope of most PAGs, challenges arise from language translation and differences in international policies, leading to issues such as limited public awareness and insufficient engagement with patients and healthcare professionals 3. Another major hurdle for the PAGs is funding.

Patients 52

Patients Recruitment Ethics Government 52

Medico Reach

FEBRUARY 8, 2023

billion during 2020-2024. Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion in 2020 and will project growth of USD 4.18

Pharma 52

Pharma Medicine Marketing Prospecting 52

Pharma Marketing Network

NOVEMBER 23, 2021

“The Healthcare Businesswomen’s (HBA) Advancement. An independent panel of healthcare industry leaders select honorees for their excellence in advancing female talent across their organizations and for their continued work in removing systemic barriers that prevent progress to parity. Commitment. Engagement. 50 percent of U.S.

Networking 52

Networking Healthcare Healthcare Specialization 52